German biotechnology company Evotec SE announced a deal on Wednesday that expands its partnership with Advanced BioScience Laboratories (ABL) to advance manufacturing processes for HIV neutralizing antibodies. The deal involved its Seattle unit Just-Evotec Biologics, it said. The financial details of the agreement were not yet disclosed. Under the terms, Just-Evotec Biologics will develop a third broadly neutralizing HIV-1 antibody (bNAb) and perform large-scale current good manufacturing practice (cGMP) manufacturing campaigns for the current bNAb and a previously developed bNAb against HIV a…